Paul N. Meyer

3.1k total citations
19 papers, 660 citations indexed

About

Paul N. Meyer is a scholar working on Pathology and Forensic Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Paul N. Meyer has authored 19 papers receiving a total of 660 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pathology and Forensic Medicine, 4 papers in Surgery and 4 papers in Molecular Biology. Recurrent topics in Paul N. Meyer's work include Lymphoma Diagnosis and Treatment (7 papers), Viral-associated cancers and disorders (3 papers) and Renal cell carcinoma treatment (2 papers). Paul N. Meyer is often cited by papers focused on Lymphoma Diagnosis and Treatment (7 papers), Viral-associated cancers and disorders (3 papers) and Renal cell carcinoma treatment (2 papers). Paul N. Meyer collaborates with scholars based in United States, Canada and Germany. Paul N. Meyer's co-authors include Kai Fu, Wing C. Chan, Timothy C. Greiner, Lynette M. Smith, Dennis D. Weisenburger, Julie M. Vose, Robert C. Flanigan, Maria M. Picken, Jan Delabie and Georg Lenz and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Infection and Immunity.

In The Last Decade

Paul N. Meyer

16 papers receiving 640 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul N. Meyer United States 11 397 281 201 167 151 19 660
CR Kjeldsberg United States 11 511 1.3× 340 1.2× 229 1.1× 141 0.8× 108 0.7× 23 713
Maria Scardoni Italy 15 253 0.6× 422 1.5× 84 0.4× 176 1.1× 136 0.9× 21 824
Gan‐di Li China 13 371 0.9× 342 1.2× 67 0.3× 128 0.8× 103 0.7× 65 641
Adam M. Petrich United States 17 554 1.4× 388 1.4× 221 1.1× 180 1.1× 59 0.4× 57 902
Manuel F. Rosado United States 10 333 0.8× 249 0.9× 97 0.5× 58 0.3× 63 0.4× 14 491
Zach Liu United States 10 263 0.7× 225 0.8× 159 0.8× 50 0.3× 125 0.8× 12 445
A Kunlin France 10 395 1.0× 268 1.0× 254 1.3× 95 0.6× 39 0.3× 18 623
PA Bryon France 9 531 1.3× 340 1.2× 356 1.8× 74 0.4× 79 0.5× 18 669
C. von Schilling Germany 11 185 0.5× 178 0.6× 91 0.5× 98 0.6× 90 0.6× 22 498
Paolo Fiumara Italy 12 303 0.8× 282 1.0× 140 0.7× 196 1.2× 49 0.3× 28 684

Countries citing papers authored by Paul N. Meyer

Since Specialization
Citations

This map shows the geographic impact of Paul N. Meyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul N. Meyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul N. Meyer more than expected).

Fields of papers citing papers by Paul N. Meyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul N. Meyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul N. Meyer. The network helps show where Paul N. Meyer may publish in the future.

Co-authorship network of co-authors of Paul N. Meyer

This figure shows the co-authorship network connecting the top 25 collaborators of Paul N. Meyer. A scholar is included among the top collaborators of Paul N. Meyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul N. Meyer. Paul N. Meyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
Caponetti, Gabriel C., Bhavana J. Davé, Anamarija M. Perry, et al.. (2015). IsolatedMYCcytogenetic abnormalities in diffuse large B-cell lymphoma do not predict an adverse clinical outcome. Leukemia & lymphoma. 56(11). 3082–3089. 10 indexed citations
3.
Taverna, Josephine A., Hani M. Babiker, Seongseok Yun, et al.. (2014). The great masquerader of malignancy: chronic intestinal pseudo-obstruction. Biomarker Research. 2(1). 23–23. 14 indexed citations
4.
Meyer, Paul N., Kai Fu, Timothy C. Greiner, et al.. (2010). The Stromal Cell Marker SPARC Predicts for Survival in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab. American Journal of Clinical Pathology. 135(1). 54–61. 52 indexed citations
5.
Meyer, Paul N., Kai Fu, Timothy C. Greiner, et al.. (2010). Immunohistochemical Methods for Predicting Cell of Origin and Survival in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab. Journal of Clinical Oncology. 29(2). 200–207. 338 indexed citations
6.
Meyer, Paul N., et al.. (2010). Diffuse large B-cell lymphoma with both CD5 and cyclin D1 expression—a case report and review of the literature. Journal of Hematopathology. 3(4). 145–148. 4 indexed citations
7.
8.
Meyer, Paul N., et al.. (2007). HSP90 inhibitor 17AAG causes apoptosis in ATRA-resistant acute promyelocytic leukemia cells. Leukemia Research. 32(1). 143–149. 11 indexed citations
9.
Meyer, Paul N., Joseph I. Clark, Robert C. Flanigan, & Maria M. Picken. (2007). Xp11.2 Translocation Renal Cell Carcinoma With Very Aggressive Course in Five Adults. American Journal of Clinical Pathology. 128(1). 70–79. 103 indexed citations
10.
Meyer, Paul N., Hytham Al‐Masri, & Serhan Alkan. (2006). Osseous metaplasia in diffuse large B‐cell lymphoma of the kidney. American Journal of Hematology. 82(4). 321–324. 5 indexed citations
11.
Sjø, Lene Dissing, E. Ralfkiaer, Birgitte Ravn Juhl, et al.. (2006). Primary lymphoma of the lacrimal sac: an EORTC ophthalmic oncology task force study. American Journal of Ophthalmology. 142(5). 897–898. 6 indexed citations
12.
Chorney, Michael J., et al.. (2003). The enigmatic role of the hemochromatosis protein (HFE) in iron absorption. Trends in Molecular Medicine. 9(3). 118–125. 14 indexed citations
13.
Meyer, Paul N., Glenn S. Gerhard, Mika Yoshida, et al.. (2002). Hemochromatosis Protein (HFE) and Tumor Necrosis Factor Receptor 2 (TNFR2) Influence Tissue Iron Levels: Elements of a Common Gut Pathway?. Blood Cells Molecules and Diseases. 29(3). 274–285. 11 indexed citations
14.
Meyer, Paul N., M R Wilmes-Riesenberg, Christos Stathopoulos, & Roy Curtiss. (1998). Virulence of aSalmonella typhimuriumOmpD Mutant. Infection and Immunity. 66(1). 387–390. 21 indexed citations
15.
Meyer, Paul N., et al.. (1974). HEPATOBLASTOMA ASSOCIATED WITH AN ORAL CONTRACEPTIVE. The Lancet. 304(7893). 1387–1387. 57 indexed citations
16.
Meyer, Paul N., et al.. (1966). [Isolated diffuse lymphomatosis of the colon. Apropos of a case report].. PubMed. 55(12). 1167–74. 1 indexed citations
17.
Meyer, Paul N., et al.. (1964). [CONGENITAL HEPATIC FIBROSIS].. PubMed. 72. 375–6. 1 indexed citations
18.
Meyer, Paul N., et al.. (1963). [ATTEMPTED CLASSIFICATION OF CYSTIC LESIONS OF THE KIDNEY AS A FUNCTION OF ASSOCIATED HEPATIC LESIONS].. PubMed. 69. 617–22. 1 indexed citations
19.
Jp, Benhamou, et al.. (1963). [Cystic dilatation of the intrahepatic bile ducts and cogenital hepatic fibrosis].. PubMed. 38. 149–62. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by CR Kjeldsberg Breakdown of academic impact, for papers by Maria Scardoni Breakdown of academic impact, for papers by Gan‐di Li Breakdown of academic impact, for papers by Adam M. Petrich Breakdown of academic impact, for papers by Manuel F. Rosado Breakdown of academic impact, for papers by Zach Liu Breakdown of academic impact, for papers by A Kunlin Breakdown of academic impact, for papers by PA Bryon Breakdown of academic impact, for papers by C. von Schilling Breakdown of academic impact, for papers by Paolo Fiumara
Rankless by CCL
2026